2024-10-17 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a leading developer and manufacturer of robotic-assisted surgery systems.

**Performance Analysis:**

**1. Return Rate vs. S&P 500:**

* ISRG has a cumulative return of 343.95%, compared to the S&P 500 (VOO) with a cumulative return of 135.94%.
* This represents a **208.01%** difference, exceeding the S&P 500 by a significant margin.
* ISRG's relative strength against the S&P 500 sits at **72.11%** on a scale of 0 to 100, indicating a historically strong performance against the benchmark.

**2. Recent Price Movement:**

* **Closing Price:** 478.47
* **5-Day Moving Average:** 485.36
* **20-Day Moving Average:** 484.26
* **60-Day Moving Average:** 475.04

ISRG's current price is slightly below its recent moving averages, suggesting a potential consolidation phase or a short-term downward correction.

**3. Technical Indicators:**

* **RSI:** 46.32, indicates a neutral to slightly oversold territory, suggesting potential for a bounce back.
* **PPO:** -0.15, signifies a bearish trend, potentially indicating a short-term downward pressure.
* **Delta_Previous_Relative_Divergence:** -4.39, suggests a recent (20-day) decline in relative strength.
* **Expected_Return:** 8.58%, indicating a potential 5-year expected return above the S&P 500 benchmark. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2023-07-24 | 1.2 | 1.76 B$ |
| 2024-07-19 | 1.2 | 1.76 B$ |

ISRG has consistently shown strong earnings growth, exceeding expectations in recent quarters. The latest earnings report (2024-07-19) demonstrated robust growth, reflecting a continued strong demand for their robotic surgery systems.

**5. News and Recent Issues:**

* **Recent Market Outlook:** ISRG is seen as a leader in the rapidly growing robotic surgery market, with continued growth expected driven by technological advancements and increasing adoption. 
* **Analyst Opinions:** The majority of analysts have a "buy" or "outperform" rating on ISRG, reflecting a positive outlook on the company's long-term prospects.
* **Performance Highlights:** ISRG's strong earnings and revenue growth, combined with its dominant market share in robotic surgery, have driven its recent price appreciation. 

**6. Summary:**

ISRG has outperformed the S&P 500 by a significant margin, exhibiting strong earnings growth and continued dominance in the robotic surgery market.  Recent technical indicators suggest a possible short-term consolidation or correction, but long-term outlook remains bullish. Analyst opinions and market trends support a positive view on ISRG's growth potential.

**7. Conclusion:**

ISRG is a leading player in the innovative and rapidly growing robotic surgery sector. Despite recent price fluctuations and technical indicators suggesting potential for short-term correction, the company's strong fundamentals, including its dominance in the market, consistent earnings growth, and positive analyst sentiments, point towards a strong long-term growth trajectory. ISRG remains a compelling investment opportunity for investors seeking exposure to the healthcare technology sector. 
